Research Output per year
Fingerprint Dive into the research topics where Giusy Gentilcore is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 37 Similar Profiles
Melanoma
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Dendritic Cells
Medicine & Life Sciences
Regulatory T-Lymphocytes
Medicine & Life Sciences
T-cells
Chemical Compounds
interferon alfa-2b
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
temozolomide
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 2009 2018
2
Citations
(Scopus)
Effect of ABT-888 on the apoptosis, motility and invasiveness of BRAFi-resistant melanoma cells
Fratangelo, F., Camerlingo, R., Carriero, M. V., Pirozzi, G., Palmieri, G., Gentilcore, G., Ragone, C., Minopoli, M., Ascierto, P. A. & Motti, M. L., 1 Sep 2018, In : International Journal of Oncology. 53, 3, p. 1149-1159 11 p.Research output: Contribution to journal › Article
Melanoma
Apoptosis
Mutation
Cell Survival
veliparib
3
Citations
(Scopus)
Lenalidomide as immune adjuvant to a dendritic cell vaccine in chronic lymphocytic leukemia patients
Palma, M., Hansson, L., Mulder, T. A., Adamson, L., Näsman-Glaser, B., Eriksson, I., Heimersson, K., Ryblom, H., Mozaffari, F., Svensson, A., Gentilcore, G., Österborg, A. & Mellstedt, H., 1 Jan 2018, (Accepted/In press) In : European Journal of Haematology.Research output: Contribution to journal › Article
B-Cell Chronic Lymphocytic Leukemia
Dendritic Cells
Vaccines
Granulocyte-Macrophage Colony-Stimulating Factor
T-Lymphocytes
21
Citations
(Scopus)
T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers
Palma, M., Gentilcore, G., Heimersson, K., Mozaffari, F., Näsman-Glaser, B., Young, E., Rosenquist, R., Hansson, L., Österborg, A. & Mellstedt, H., 28 Feb 2017, In : Haematologica. 102, 3, p. 562-572 11 p.Research output: Contribution to journal › Article
T-Cell Prolymphocytic Leukemia
T-Lymphocytes
CTLA-4 Antigen
B-Cell Chronic Lymphocytic Leukemia
Regulatory T-Lymphocytes
35
Citations
(Scopus)
Assessing a novel immuno-oncology-based combination therapy: Ipilimumab plus electrochemotherapy
Mozzillo, N., Simeone, E., Benedetto, L., Curvietto, M., Giannarelli, D., Gentilcore, G., Camerlingo, R., Capone, M., Madonna, G., Festino, L., Caracò, C., Di Monta, G., Marone, U., Di Marzo, M., Grimaldi, A. M., Mori, S., Ciliberto, G. & Ascierto, P. A., 1 Jan 2015, In : OncoImmunology. 4, 6Research output: Contribution to journal › Article
Electrochemotherapy
Melanoma
Therapeutics
CTLA-4 Antigen
Bleomycin
Ipilimumab treatment decreases circulating Tregs and GrMDSC while enhancing CD4+ T cell activation
Pico de Coaña, Y., Wolodarski, M., Gentilcore, G., Yoshimoto, Y., Poschke, I., Hansson, J., Masucci, G. V. & Kiessling, R., 15 Jan 2015, (Accepted/In press) In : Journal of Translational Medicine. p. 1 1 p.Research output: Contribution to journal › Article
T-Lymphocytes
ipilimumab